Abstract: In this presentation we will share our journey towards scaling our R-usage from our first submission, and the feedback we have received from authorities in doing so.
  
  We will highlight our strategic direction and what role open-source will play for Novo Nordisk in future submissions.
Speaker: Ari Siggaard Knoph, Ari Siggaard Knoph and Steffen Falgreen Larsen
Affiliation: Novo Nordisk
Title: Our R-Based Submissions: A 1-year follow-up, Lessons Learned, and Future Strategies
Abstract_Sanitzed: In this presentation we will share our journey towards scaling our R-usage from our first submission, and the feedback we have received from authorities in doing so.  We will highlight our strategic direction and what role open-source will play for Novo Nordisk in future submissions.